Genomind Releases Statement Supporting NIMH Announcement To Move Away From DSM Categories
Genomind Releases Statement Supporting NIMH Announcement To Move Away From DSM Categories
Genomind Microsite Wins “Best In Class” Award
Genomind Microsite Wins “Best In Class” Award
Genomind To Participate In NAPHS Annual Meeting
Genomind To Participate In NAPHS Annual Meeting
Genomind To Spend Week Educating Industry Leaders
Genomind To Spend Week Educating Industry Leaders
Genomind To Exhibit At Two Upcoming Mental Health Conferences
Genomind To Exhibit At Two Upcoming Mental Health Conferences
Genomind Announces New Portal At NEI Global Psychopharmacology Congress
Genomind Announces New Portal At NEI Global Psychopharmacology Congress
Genomind Executive To Speak At Open Minds Technology & Informatics Institute
Genomind Executive To Speak At Open Minds Technology & Informatics Institute
Rudolph E. Tanzi, Ph.D. Joins Genomind’s Scientific Advisory Board
Rudolph E. Tanzi, Ph.D. Joins Genomind’s Scientific Advisory Board
Genomind Announces New Scientific Advisory Board Member
Genomind Announces New Scientific Advisory Board Member
Genomind Welcomes New Executive Team Member Hill Meade
Genomind Welcomes New Executive Team Member Hill Meade
Genomind To Participate In National Alliance On Mental Illness (NAMI) 2012 National Convention
Genomind To Participate In National Alliance On Mental Illness (NAMI) 2012 National Convention
Genomind Supports Neuroscience Education Institute (NEI) With Grant To Further Knowledge Of Personalized Medicine Among Health Professionals
Genomind Supports Neuroscience Education Institute (NEI) With Grant To Further Knowledge Of Personalized Medicine Among Health Professionals
Genomind Supports Massachusetts General Hospital (MGH) Psychiatry Academy With Grant For Live Learning Symposium On Biomarkers In Psychiatry
Genomind Supports Massachusetts General Hospital (MGH) Psychiatry Academy With Grant For Live Learning Symposium On Biomarkers In Psychiatry
Genomind Presents Open Label Study Protocol Designed To Assess The Genecept Assay In Actual Clinical Practice At American Psychiatric Association Annual Meeting
Genomind Presents Open Label Study Protocol Designed To Assess The Genecept Assay In Actual Clinical Practice At American Psychiatric Association Annual Meeting
New Chief Sales Executive To Lead Effort To Expand Adoption Of The Genecept Assay
New Chief Sales Executive To Lead Effort To Expand Adoption Of The Genecept™ Assay
Dr. Jay Lombard Of Genomind Selected To Speak At TEDMED 2012
Dr. Jay Lombard Of Genomind Selected To Speak At TEDMED 2012 On “The New Map For Mental Illness”
Enhanced Biomarker Test Aids Clinicians With Difficult To Treat Psychiatric Patients
Enhanced Biomarker Test Aids Clinicians With Difficult To Treat Psychiatric Patients
Genomind Announces New Enhancements To Leadership Team
Genomind Announces New Enhancements To Leadership Team
Centerstone And Genomind Begin New Study On Genetic Test For Patients With Major Depressive Disorder
Centerstone And Genomind Begin New Study On Genetic Test For Patients With Major Depressive Disorder
Genomind Announces Inpatient Study With Massachusetts General Hospital Of Genetic Biomarkers In Treatment Resistant Depression
Genomind Announces Inpatient Study With Massachusetts General Hospital Of Genetic Biomarkers In Treatment Resistant Depression
Schlosspark-Klinik Presents Successful Case History Using Genomind’S Genecept™ Assay At The German Association For Psychiatry And Psychotherapy 2011 Annual Meeting
Schlosspark-Klinik Presents Successful Case History Using Genomind’S Genecept™ Assay At The German Association For Psychiatry And Psychotherapy 2011 Annual Meeting
Personalized Medicine Offers New Hope To People With Depression
Personalized Medicine Offers New Hope To People With Depression
Pharmacogenetic Testing In Psychiatric Populations Found To Increase Clinician Confidence In Treatment Decisions
Pharmacogenetic Testing In Psychiatric Populations Found To Increase Clinician Confidence In Treatment Decisions
Genecept Assay Increases Clinician Confidence In Treatment Decisions
Genecept Assay Increases Clinician Confidence In Treatment Decisions
Genomind To Present New Results At ISCTM Autumn Conference On “Pharmacogenetic Testing In Psychiatric Populations”
Genomind To Present New Results At ISCTM Autumn Conference On “Pharmacogenetic Testing In Psychiatric Populations”
Genomind Adds Allan I. Levey, Md, Phd, And Anil Malhotra, Md, To Its Scientific Advisory Board
Genomind Adds Allan I. Levey, Md, Phd, And Anil Malhotra, Md, To Its Scientific Advisory Board
Genomind Adds Thomas D. Bartel As Chief Sales Officer To Accelerate Successful Commercial Adoption Of The Genecept Assay
Genomind Adds Thomas D. Bartel As Chief Sales Officer To Accelerate Successful Commercial Adoption Of The Genecept Assay
Leading Healthcare Executives Join Genomind To Advance Personalized Medicine In Psychiatry
Leading Healthcare Executives Join Genomind To Advance Personalized Medicine In Psychiatry
Genomind Education Grant To Neuroscience Education Institute (NEI) Explores Genotyping In Psychiatry
Genomind Education Grant To Neuroscience Education Institute (NEI) Explores Genotyping In Psychiatry
Genomind Presents At 2011 NAMI Convention On Emerging Technologies To Improve Care
Genomind Presents At 2011 NAMI Convention On Emerging Technologies To Improve Care